BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 24501429)

  • 1. ONSL and OSKM cocktails act synergistically in reprogramming human somatic cells into induced pluripotent stem cells.
    Jung L; Tropel P; Moal Y; Teletin M; Jeandidier E; Gayon R; Himmelspach C; Bello F; André C; Tosch A; Mansouri A; Bruant-Rodier C; Bouillé P; Viville S
    Mol Hum Reprod; 2014 Jun; 20(6):538-49. PubMed ID: 24501429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NKX3-1 is required for induced pluripotent stem cell reprogramming and can replace OCT4 in mouse and human iPSC induction.
    Mai T; Markov GJ; Brady JJ; Palla A; Zeng H; Sebastiano V; Blau HM
    Nat Cell Biol; 2018 Aug; 20(8):900-908. PubMed ID: 30013107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CXCR2 Ligands and mTOR Activation Enhance Reprogramming of Human Somatic Cells to Pluripotent Stem Cells.
    Lee SJ; Kang KW; Kim JH; Lee BH; Jung JH; Park Y; Hong SC; Kim BS
    Stem Cells Dev; 2020 Feb; 29(3):119-132. PubMed ID: 31808362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
    Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
    Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
    Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
    J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. OCT4 activity during conversion of human intermediately reprogrammed stem cells to iPSCs through mesenchymal-epithelial transition.
    Teshigawara R; Hirano K; Nagata S; Ainscough J; Tada T
    Development; 2016 Jan; 143(1):15-23. PubMed ID: 26657769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The timing of retroviral silencing correlates with the quality of induced pluripotent stem cell lines.
    Okada M; Yoneda Y
    Biochim Biophys Acta; 2011 Feb; 1810(2):226-35. PubMed ID: 20965232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors.
    Ramos-Mejía V; Montes R; Bueno C; Ayllón V; Real PJ; Rodríguez R; Menendez P
    PLoS One; 2012; 7(4):e35824. PubMed ID: 22545141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
    Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
    Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human transcription factors responsive to initial reprogramming predominantly undergo legitimate reprogramming during fibroblast conversion to iPSCs.
    Cevallos RR; Edwards YJK; Parant JM; Yoder BK; Hu K
    Sci Rep; 2020 Nov; 10(1):19710. PubMed ID: 33184372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human fibroblast reprogramming to pluripotent stem cells regulated by the miR19a/b-PTEN axis.
    He X; Cao Y; Wang L; Han Y; Zhong X; Zhou G; Cai Y; Zhang H; Gao P
    PLoS One; 2014; 9(4):e95213. PubMed ID: 24740298
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular insights into reprogramming-initiation events mediated by the OSKM gene regulatory network.
    Mah N; Wang Y; Liao MC; Prigione A; Jozefczuk J; Lichtner B; Wolfrum K; Haltmeier M; Flöttmann M; Schaefer M; Hahn A; Mrowka R; Klipp E; Andrade-Navarro MA; Adjaye J
    PLoS One; 2011; 6(8):e24351. PubMed ID: 21909390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming.
    Nishimura K; Kato T; Chen C; Oinam L; Shiomitsu E; Ayakawa D; Ohtaka M; Fukuda A; Nakanishi M; Hisatake K
    Stem Cell Reports; 2014 Nov; 3(5):915-29. PubMed ID: 25418733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα.
    Bueno C; Sardina JL; Di Stefano B; Romero-Moya D; Muñoz-López A; Ariza L; Chillón MC; Balanzategui A; Castaño J; Herreros A; Fraga MF; Fernández A; Granada I; Quintana-Bustamante O; Segovia JC; Nishimura K; Ohtaka M; Nakanishi M; Graf T; Menendez P
    Leukemia; 2016 Mar; 30(3):674-82. PubMed ID: 26500142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zic3 enhances the generation of mouse induced pluripotent stem cells.
    Declercq J; Sheshadri P; Verfaillie CM; Kumar A
    Stem Cells Dev; 2013 Jul; 22(14):2017-25. PubMed ID: 23421367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear reprogramming with a non-integrating human RNA virus.
    Driscoll CB; Tonne JM; El Khatib M; Cattaneo R; Ikeda Y; Devaux P
    Stem Cell Res Ther; 2015 Mar; 6(1):48. PubMed ID: 25889591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial somatic to stem cell transformations induced by cell-permeable reprogramming factors.
    Lim J; Kim J; Kang J; Jo D
    Sci Rep; 2014 Mar; 4():4361. PubMed ID: 24618595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OSKM Induce Extraembryonic Endoderm Stem Cells in Parallel to Induced Pluripotent Stem Cells.
    Parenti A; Halbisen MA; Wang K; Latham K; Ralston A
    Stem Cell Reports; 2016 Apr; 6(4):447-455. PubMed ID: 26947975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induced pluripotent stem cell generation from bovine somatic cells indicates unmet needs for pluripotency sustenance.
    Pillai VV; Kei TG; Reddy SE; Das M; Abratte C; Cheong SH; Selvaraj V
    Anim Sci J; 2019 Sep; 90(9):1149-1160. PubMed ID: 31322312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conversion of partially reprogrammed cells to fully pluripotent stem cells is associated with further activation of stem cell maintenance- and gamete generation-related genes.
    Kim JS; Choi HW; Choi S; Seo HG; Moon SH; Chung HM; Do JT
    Stem Cells Dev; 2014 Nov; 23(21):2637-48. PubMed ID: 24892478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.